- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
13
Mid-Large Cap Stocks
13 companies
Novartis
Market Cap: CHF 231.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 126.28
7D
6.7%
1Y
31.3%
Roche Holding
Market Cap: CHF 268.0b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 336.00
7D
5.1%
1Y
28.4%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 162.60
7D
7.2%
1Y
0.6%
Bachem Holding
Market Cap: CHF 5.4b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 71.90
7D
5.8%
1Y
21.9%
Sandoz Group
Market Cap: CHF 31.1b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 71.88
7D
5.8%
1Y
65.8%
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 65.90
7D
-3.8%
1Y
15.8%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 54.30
7D
10.1%
1Y
-23.9%
Galderma Group
Market Cap: CHF 41.8b
Operates as a dermatology company worldwide.
GALD
CHF 178.25
7D
3.4%
1Y
50.4%
Lonza Group
Market Cap: CHF 37.3b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 534.60
7D
7.2%
1Y
-5.6%
Dottikon ES Holding
Market Cap: CHF 3.8b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 275.00
7D
-9.4%
1Y
-7.7%
Idorsia
Market Cap: CHF 1.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 6.86
7D
20.9%
1Y
239.6%
Siegfried Holding
Market Cap: CHF 3.1b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 70.00
7D
3.0%
1Y
-21.4%
PolyPeptide Group
Market Cap: CHF 1.5b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 46.50
7D
18.2%
1Y
127.9%